Authors:
Liu, XS
Shi, Y
Han, EKH
Chen, ZH
Rosenberg, SH
Giranda, VL
Luo, Y
Ng, SC
Citation: Xs. Liu et al., Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells, NEOPLASIA, 3(4), 2001, pp. 278-286
Authors:
Luo, Y
Rockow-Magnone, SK
Joseph, MK
Bradner, J
Butler, CC
Tahir, SK
Han, EKH
Ng, SC
Severin, JM
Gubbins, EJ
Reilly, RM
Rueter, A
Simmer, RL
Holzman, TF
Giranda, VL
Citation: Y. Luo et al., Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents, ANTICANC R, 21(1A), 2001, pp. 23-28
Authors:
Klinghofer, V
Stewart, K
McGonigal, T
Smith, R
Sarthy, A
Nienaber, V
Butler, C
Dorwin, S
Richardson, P
Weitzberg, M
Wendt, M
Rockway, T
Zhao, XM
Hulkower, KI
Giranda, VL
Citation: V. Klinghofer et al., Species specificity of amidine-based urokinase inhibitors, BIOCHEM, 40(31), 2001, pp. 9125-9131
Citation: Vl. Nienaber et al., Discovering novel ligands for macromolecules using X-ray crystallographic screening, NAT BIOTECH, 18(10), 2000, pp. 1105-1108
Authors:
Nienaber, VL
Davidson, D
Edalji, R
Giranda, VL
Klinghofer, V
Henkin, J
Magdalinos, P
Mantei, R
Merrick, S
Severin, JM
Smith, RA
Stewart, K
Walter, K
Wang, JY
Wendt, M
Weitzberg, M
Zhao, XM
Rockway, T
Citation: Vl. Nienaber et al., Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite, STRUCT F D, 8(5), 2000, pp. 553-563
Authors:
Bussiere, DE
Kong, XP
Egan, DA
Walter, K
Holzman, TF
Lindh, F
Robins, T
Giranda, VL
Citation: De. Bussiere et al., Structure of the E2 DNA-binding domain from human papillomavirus serotype 31 at 2.4 angstrom, ACT CRYST D, 54, 1998, pp. 1367-1376